Twist Bioscience Announces Participation in SRC-SIA Webinar on the Decadal Plan for Semiconductors

Twist Bioscience to Present at Upcoming Virtual Conferences

Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results

Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities

Twist Bioscience Expands Partnership with Invetx to Include Discovery of Best-in-Class Antibodies to Treat Multiple Diseases in Cats and Dogs

Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases

Twist Bioscience to Present at the Stifel 2021 Virtual Healthcare Conference

Twist Bioscience Named in Inc.’s First Annual Best-Led Companies List

Twist Bioscience to Report Fiscal 2021 Fourth Quarter and Full Year Financial Results on Monday, November 22, 2021

Twist Bioscience Launches Exome 2.0 for Genomics Research